Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Residue trypsin inhibitor: data needs for risk assessment.

J N Hathcock1

  • 1Center for Food Safety and Applied Nutrition, Food and Drug Administration, Washington, DC 20204.

Advances in Experimental Medicine and Biology
|January 1, 1991
PubMed
Summary

Plant-based trypsin inhibitors (TI) remain active after heating, potentially promoting pancreatic cancer. Further research is needed to assess human health risks from dietary TI exposure.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dietary supplements: what is in the public's best interest?

Science (New York, N.Y.)·2000
Same author

Over-the-counter chromium and renal failure.

Annals of internal medicine·1997
Same author

Vitamins and minerals: efficacy and safety.

The American journal of clinical nutrition·1997
Same author

Safety limits for nutrients.

The Journal of nutrition·1996
Same author

Applications of antioxidants in physiologically functional foods: safety aspects.

Critical reviews in food science and nutrition·1995
Same author

Marginal zinc status does not exacerbate pancreatic carcinogenesis associated with dietary soybean trypsin inhibitor concentrate in rats.

The Journal of nutrition·1994

Area of Science:

  • Nutritional biochemistry
  • Toxicology
  • Food science

Background:

  • Trypsin inhibitor (TI) is a common plant-derived compound found in foods like soybean products.
  • Heat treatment reduces TI activity but 5-20% often remains, posing potential health concerns.
  • Chronic TI exposure can lead to pancreatic issues, including hyperplasia, hypertrophy, and cancer promotion.

Purpose of the Study:

  • To evaluate the health risks associated with residual trypsin inhibitor activity in foods.
  • To identify data gaps for a comprehensive risk assessment of dietary TI.
  • To understand the interaction of TI with other dietary factors in pancreatic carcinogenesis.

Main Methods:

  • Review of existing literature on TI effects on pancreatic health and carcinogenesis.
  • Analysis of factors influencing TI activity and human exposure.
  • Consideration of data requirements for animal bioassays and risk assessment.

Main Results:

  • Residual TI can inhibit digestive enzymes and stimulate pancreatic secretion.
  • TI promotes azaserine-initiated pancreatic carcinogenesis in rats.
  • Dietary fat acts as a co-promoter in TI-induced pancreatic carcinogenesis.
  • Reducing human dietary TI exposure is challenging due to multiple sources and processing limitations.

Conclusions:

  • Comprehensive risk assessment requires long-term animal studies with controlled diets.
  • TI's role in pancreatic cancer necessitates consideration of other dietary promoters like fat.
  • Minimizing TI intake may not be feasible, highlighting the need for nuanced risk management strategies.

Related Experiment Videos